Cite
Naito Y, Ishikawa H, Sadashima E, et al. Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis. Mol Clin Oncol. 2019;11(3):225-233doi: 10.3892/mco.2019.1885.
Naito, Y., Ishikawa, H., Sadashima, E., Okabe, Y., Takahashi, K., Kawahara, R., Hisaka, T., Fukahori, M., Ushijima, T., Ishida, Y., Tanigawa, M., Mihara, Y., Nakayama, M., Kondo, R., Kusano, H., Takase, Y., Abe, H., Ogo, E., Okuda, K., Shimamatsu, K., Yano, H., & Akiba, J. (2019). Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis. Molecular and clinical oncology, 11(3), 225-233. https://doi.org/10.3892/mco.2019.1885
Naito, Yoshiki, et al. "Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis." Molecular and clinical oncology vol. 11,3 (2019): 225-233. doi: https://doi.org/10.3892/mco.2019.1885
Naito Y, Ishikawa H, Sadashima E, Okabe Y, Takahashi K, Kawahara R, Hisaka T, Fukahori M, Ushijima T, Ishida Y, Tanigawa M, Mihara Y, Nakayama M, Kondo R, Kusano H, Takase Y, Abe H, Ogo E, Okuda K, Shimamatsu K, Yano H, Akiba J. Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis. Mol Clin Oncol. 2019 Sep;11(3):225-233. doi: 10.3892/mco.2019.1885. Epub 2019 Jun 20. PMID: 31423309; PMCID: PMC6688216.
Copy
Download .nbib